Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Seongnam-si
Clinical trial register · South Korea

Clinical Trials in Seongnam-si, 2026

Every study on the ClinicalTrials.gov registry that lists a site in South Korea and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3401 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:18 UTC
3401
Studies in scope
all four open statuses
1867
Recruiting now
open to new participants
507
Lead sponsors
across recruiting studies
Top sites
Seoul 2859 Daegu 553 Seongnam-si 482 Busan 469 Goyang-si 397

Trials with a site in Seongnam-si

482 of 3401 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
Not yet open
Dong-A University Hospital
Not applicable
60
Busan, Seongnam-si, Seoul
2026-11-29
Not yet open
Novo Nordisk A/S
Phase 3
1,408
Anyang-si, Bucheon-si, Seongnam-si, Yangsan, Busan, Daegu, Daejeon, Seoul
2026-11-11
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Bucheon-si, Seongnam-si, Suwon, Uijeongbu-si, Yangsan, Busan, Daegu, Daejeon
2026-10-26
Recruiting
Hoffmann-La Roche
Phase 3
400
Seongnam-si, Busan, Daegu, Daejeon, Gyeonggi-do, Incheon, Jeollanam-do, Seoul
2026-10-06
Not yet open
CHA University
Observational
100
Seongnam-si
2026-10-01
Recruiting
Corbus Pharmaceuticals Inc.
Phase 3
260
Busan, Jeonju, Seongnam, Seongnam-si, Seoul, Suwon, Yangsan
2026-09-29
Recruiting
BREZTRI REGULATORY POST MARKETING SURVEILLANCE IN KOREA
NCT07570394Chronic Obstructive Pulmonary Disease (COPD), Asthma
AstraZeneca
Observational
600
Chuncheon, Daegu, Goyang-si, Gwangmyeong, Jinju, Seongnam-si, Seoul, Wŏnju
2026-09-17
Recruiting
Daiichi Sankyo
Phase 1/2
220
Seongnam-si, Seoul
2026-09-17
Recruiting
AstraZeneca
Phase 3
950
Busan, Daegu, Goyang-si, Gyeonggi-do, Seongnam-si, Seoul, Yangsan
2026-09-16
Recruiting
Takeda
Phase 3
324
Seoul, Seongnam-si, Daegu
2026-09-10
Recruiting
Bristol-Myers Squibb
Phase 3
850
Cheongju-si, Buk-Gu, Dalseo, Goyang-si, Seongnam-si, Hwasun-Gun, Seocho -Gu, Songpa-Gu
2026-09-08
Recruiting
Incyte Corporation
Phase 3
426
Busan, Seongnam-si, Seoul
2026-09-08
Not yet open
CHA University
Phase 2
51
Seongnam-si
2026-09-01
Not yet open
AI-ECG for Preoperative Cardiovascular Risk Stratification Before General Surgery
NCT07774689Perioperative Cardiovascular Risk, Postoperative Complications (Cardiopulmonary), Preoperative Care
Seoul National University Bundang Hospital
Not applicable
3,200
Seongnam-si
2026-09-01
Not yet open
Bundang CHA Hospital
Observational
1
Seongnam-si
2026-09
Not yet open
Seoul National University Bundang Hospital
Phase 4
294
Seongnam-si
2026-09
Not yet open
Seoul National University Hospital
Not applicable
3,000
Seongnam-si, Uijeongbu-si, Daegu, Seoul
2026-08-24
Recruiting
STEPwise De-escalation and Optimizing Withdrawal of ARNI and SGLT2i in Normalized Heart Failure
NCT07631156Heart Failure With Reduced Ejection Fraction, Heart Failure, Ventricular Dysfunction, Left
Kyungsub Song
Phase 4
80
Daegu, Seongnam-si, Suwon, Yangsan, Seoul
2026-08-12
Recruiting
BELL Therapeutics Inc.
Not applicable
40
Incheon, Seongnam-si, Seoul
2026-07-20
Active, closed
Bioequivalence Study of SKI-O-703 in Healthy Adults Under Fed Conditions
NCT07675226Bioequivalence Study in Healthy Subjects, Immune Thrombocytopenia (ITP), Rheumatoid Arthritis (RA)
Oscotec Inc.
Phase 1
48
Seongnam-si
2026-07-10
Recruiting
Effects of a Prebiotic-Probiotic Combination on Constipation Symptoms and Quality of Life
NCT07923279Constipation, Abdominal Pain, Abdominal Bloating, Abdominal Discomfort
Seoul National University Hospital
Not applicable
40
Seongnam-si
2026-07-10
Active, closed
MORA Cure for Knee Osteoarthritis With Anterior Knee Pain
NCT07769593Knee Osteoarthritis, Anterior Knee Pain
EverEx Inc.
Not applicable
44
Seongnam-si, Dongjak
2026-07-10
Recruiting
SK Bioscience Co., Ltd.
Phase 3
780
Daegu, Ansan, Hwaseong-si, Seongnam-si, Incheon, Seoul
2026-07-04
Recruiting
Contrast-Induced Acute Kidney Injury Prevention in Acute Heart Failure
NCT07550790Heart Failure Acute, Renal Dysfunction
Jin Joo Park
Not applicable
190
Seongnam-si
2026-07-01
By invitation
Seoul National University Bundang Hospital
Not applicable
150
Seongnam-si
2026-06-30
Not yet open
Remimazolam on the Incidence of Postoperative Acute Kidney Injury
NCT07674719Remimazolam, Propofol, Acute Kidney Injury, Hemodynamic Stability
Seoul National University Bundang Hospital
Not applicable
78
Seongnam-si
2026-06-26
Recruiting
HieraBio Inc.
Phase 1
12
Seongnam-si
2026-06-23
By invitation
Seoul National University Bundang Hospital
Phase 1/2
93
Seongnam-si
2026-06-15
Recruiting
AstraZeneca
Phase 3
150
Cheonan-si, Daegu, Goyang-si, Hwasun-eup, Incheon, Seongbuk-Gu, Seongnam-si, Seoul
2026-06-15
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
NCT07652658Idiopathic Pulmonary Fibrosis (IPF)
AstraZeneca
Phase 2
359
Seongnam-si, Seoul
2026-06-11
Not yet open
Hallym University
Not applicable
80
Hwaseong-si, Seongnam-si
2026-06
Recruiting
Samsung Medical Center
Observational
396
Daegu, Daejeon, Seongnam-si, Yangsan, Incheon, Jeju City, Jeonju, Hwasun
2026-05-28
Recruiting
Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot Study
NCT07572032Heart Failure Due to Coronary Artery Disease, Valvular Cardiomyopathy, Heart Failure
Kyungsub Song
Phase 4
80
Daegu, Seongnam-si, Suwon, Seoul
2026-05-20
Recruiting
Jade Biosciences, Inc.
Phase 2
30
Anyang-si, Seongnam-si, Seoul, Suwon
2026-05-19
Recruiting
CHA University
Phase 2
80
Seongnam-si
2026-05-14
Recruiting
Astellas Pharma Global Development, Inc.
Phase 3
390
Daegu, Seongnam-si, Seoul
2026-05-11
Recruiting
Ningbo Newbay Technology Development Co., Ltd
Phase 2/3
255
Seongnam-si, Seoul
2026-05-11
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Wŏnju, Anyang-si, Seongnam-si, Suwon, Uijeongbu-si, Yangsan, Daegu, Daejeon
2026-05-11
Recruiting
A Study of PLH-2301 in Subjects With Sarcopenia
NCT07390552Sarcopenia in Elderly
Pluto Inc.
Phase 2
168
Seongnam-si, Suwon, Seoul
2026-05-08
Recruiting
Acute Heart Failure Registry
NCT07601022Acute Heart Failure (AHF)
Jin Joo Park
Observational
400
Seongnam-si
2026-05-08
Recruiting
EMD Serono Research & Development Institute, Inc.
Phase 3
1,020
Goyang-si, Seongnam-si, Daegu, Seoul
2026-05-06
Recruiting
Seoul National University Bundang Hospital
Phase 4
1,200
Seongnam-si
2026-05-06
Not yet open
Exploratory Trial of the "HiDongDong" Language Rehabilitation App for Articulation Delay.
NCT07613268Speech Sound Disorder, Language Development Disorders, Phonological Disorder
Seoul National University Bundang Hospital
Not applicable
48
Seongnam-si
2026-05
Not yet open
Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study
NCT07522138Home Exercise Program, PD - Parkinson's Disease, Feasibility Studies
Seoul National University Hospital
Not applicable
15
Seongnam-si
2026-04-20
Active, closed
Aribio Lab Co., Ltd.
Phase 2
135
Daegu, Seongnam-si, Yongin, Jeonju, Seoul
2026-04-17
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
150
Seongnam-si, Seoul
2026-04-16
Recruiting
Incyte Corporation
Phase 3
588
Goyang-si, Seongnam-si, Seoul
2026-04-09
Recruiting
EMD Serono Research & Development Institute, Inc.
Phase 3
202
Seoul, Seongnam-si
2026-04-01
Recruiting
AstraZeneca
Phase 1
40
Seongnam-si, Seoul
2026-03-31
Recruiting
Eisai Inc.
Phase 2
64
Seongnam-si, Daegu, Seoul, Suwon
2026-03-26
Recruiting
Hoffmann-La Roche
Phase 3
1,600
Seongnam-si, Daejeon, Gangwon-do, Gwangju, Gyeonggi-do, Seoul
2026-03-23
Recruiting
Hoffmann-La Roche
Phase 3
2,000
Daegu, Seongnam-si, Daejeon, Gwangju, Gyeonggi-do, Incheon, Seoul
2026-03-16
Active, closed
Executive Function Training Program for Children With ASD
NCT07801833Autism Spectrum Disorder
Seoul National University Bundang Hospital
Not applicable
40
Seongnam-si
2026-03-12
Recruiting
Astellas Pharma Global Development, Inc.
Phase 2
240
Seongnam-si, Hwasun, Gyeonggi-do, Seoul
2026-03-12
Recruiting
Hoffmann-La Roche
Phase 2
100
Seongnam-si, Seoul
2026-03-11
Recruiting
Seoul National University Bundang Hospital
Observational
80
Seongnam-si
2026-03-11
Recruiting
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
NCT07332481Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE)
EMD Serono Research & Development Institute, Inc.
Phase 3
202
Ansan-si, Seongnam-si, Incheon, Seoul
2026-03-10
Not yet open
Surface Electromyographic Analysis of Normal Swallowing in Children: An Exploratory Study
NCT07455279Normal Pediatric Swallowing Physiology, Swallowing Muscle Activation Patterns in Children, Swallowing Function
Seoul National University Bundang Hospital
Observational
30
Seongnam-si
2026-03-09
Recruiting
Incyte Corporation
Phase 3
700
Changwon-si, Goyang-si, Seongnam, Seongnam-si, Seoul, Suwon
2026-03-05
Active, closed
Seoul National University Bundang Hospital
Not applicable
60
Seoul, Seongnam-si
2026-02-19
Recruiting
Crescent Biopharma, Inc.
Phase 1/2
540
Songpa-dong, Seongnam-si, Seoul
2026-02-17
Recruiting
Astellas Pharma Global Development, Inc.
Phase 3
614
Cheongju-si, Incheon, Seongnam-si, Seoul, Suwon
2026-02-17
Recruiting
Hanmi Pharmaceutical Company Limited
Phase 2
45
Seongnam-si, Hwasun, Busan, Daegu, Daejeon, Seoul
2026-02-12
Not yet open
Epigenetic Factors of Colorectal Adenoma in Korean
NCT07366554Colorectal Adenoma, Colorectal Cancer Precancerous Lesion
Bundang CHA Hospital
Observational
32
Seongnam-si
2026-02-10
Recruiting
Seoul National University Hospital
Not applicable
58
Seongnam-si
2026-02-04
Recruiting
AstraZeneca
Phase 3
2,130
Daegu, Hwasun-gun, Seongnam-si, Seoul
2026-02-03
Not yet open
Seoul National University Bundang Hospital
Not applicable
20
Seongnam-si
2026-01-30
Recruiting
AbbVie
Phase 2
165
Busan, Bucheon-si, Seongnam-si, Seoul
2026-01-23
Recruiting
BeOne Medicines
Phase 3
500
Seongnam-si, SeochoGu, SeodaemunGu, Seoul, SongpaGu
2026-01-22
Recruiting
Seoul National University Bundang Hospital
Observational
360
Seongnam-si
2026-01-22
Recruiting
Servier Bio-Innovation LLC
Phase 1
30
Seongnam-si, Seoul
2026-01-14
Recruiting
Contineum Therapeutics
Phase 2
324
Seoul, Bucheon-si, Seongnam-si, Songpa-dong, Incheon
2026-01-08
Recruiting
ROKIT Healthcare
Phase 4
104
Daegu, Bucheon-si, Guri-si, Gwangmyeong, Seongnam-si, Goyang, Incheon, Jeonju
2025-12-29
Recruiting
AstraZeneca
Phase 3
1,100
Busan, Daegu, Goyang-si, Seongnam-si, Seoul, Suwon, Yangsan
2025-12-29
Recruiting
Taiho Oncology, Inc.
Phase 3
360
Daegu, Seongnam-si, Suwon, Cheongju-si, Goyang-si, Pusan, Yangsan, Jinju
2025-12-22
Recruiting
Study to Assess the Effect of OCT-598 in Patients With Advanced Solid Tumors
NCT07358806Solid Tumor, Breast Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer
Oscotec Inc.
Phase 1
51
Goyang-si, Seongnam-si, Seoul
2025-12-18
Recruiting
Merck Sharp & Dohme LLC
Phase 2
180
Goyang-si, Seongnam-si, Cheongju-si, Seoul
2025-12-12
Recruiting
Seoul National University Bundang Hospital
Phase 2
20
Seongnam-si, Seoul
2025-12-10
Recruiting
Incyte Corporation
Phase 3
466
Ansan-si, Changwon-si, Daegu, Goyang-si, Seongnam-si, Seoul
2025-12-09
Recruiting
AstraZeneca
Phase 3
1,100
Busan, Daegu, Seongnam-si, Seoul
2025-12-04
Recruiting
Deepsonbio
Not applicable
138
Cheonan, Hwaseong-si, Incheon, Seongnam-si, Suwon, Seoul
2025-11-20
Active, closed
Bayer
Phase 2
60
Seongnam-si, Seoul
2025-11-19
Recruiting
Onconic Therapeutics Inc.
Phase 1
96
Seongnam-si
2025-11-17
Recruiting
UCB Biopharma SRL
Phase 3
320
Anyang-si, Bucheon-si, Busan, Gwangju, Jeonju, Seongnam-si, Seoul
2025-11-14
Active, closed
Hoffmann-La Roche
Phase 3
1,060
Busan, Gwangju, Gyeonggi-do, Incheon, Seongnam-si, Seoul
2025-11-12
By invitation
Novo Nordisk A/S
Observational
500
Goyang-si, Seongnam-si, Suwon, Uijeongbu-si, Yangsan, Busan, Daegu, Daejeon
2025-11-10
Recruiting
AstraZeneca
Phase 2
435
Anyang-si, Cheongju-si, Daegu, Seongnam-si, Seoul, Ulsan
2025-11-06
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
NCT07085767Breast Cancer, Locally Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
Olema Pharmaceuticals, Inc.
Phase 3
1,000
Busan, Daegu, Goyang-si, Seongnam-si, Suwon, Yongin-si, Seoul
2025-11-03
Recruiting
BioNTech SE
Phase 3
558
Cheonan, Cheongju-si, Goyang-si, Seongnam-si, Seoul, Suwon
2025-10-30
Recruiting
Samsung Medical Center
Observational
2,200
Seongnam-si, Seoul
2025-10-28
Recruiting
AstraZeneca
Observational
130
Busan, Daejeon, Goyang-si, Guri-si, Incheon, Seongnam-si, Seoul, Suwon
2025-10-15
Recruiting
Janssen Research & Development, LLC
Phase 2/3
1,092
Busan, Daegu, Daejeon, Dongdaemun-gu, Seongnam-si, Seoul, Suwon
2025-10-03
Recruiting
Pfizer
Phase 2/3
982
Incheon, Seongnam, Seongnam-si, Seoul, Daegu, Busan
2025-10-03
Recruiting
Novo Nordisk A/S
Phase 3
1,280
Seongnam-si, Busan, Seoul
2025-10-02
Recruiting
Pfizer
Phase 3
680
Cheongju-si, Goyang-si, Seongnam, Seongnam-si, Suwon, Haeundae-gu, Dongjak-gu, Seoul
2025-09-29
Recruiting
A Study of PHN-012 in Patients With Advanced Solid Tumors
NCT07127874Colon Cancer, Pancreatic Cancer, Lung Cancer (NSCLC), Advanced Cancer
Pheon Therapeutics
Phase 1
165
Seoul, Seongnam-si
2025-09-23
Recruiting
Bristol-Myers Squibb
Phase 3
3,040
Seongnam-si, Gyeonggi-do, Dongdaemun-gu, Jongno-gu, Busan, Donggu, Seongnam-si, Seoul
2025-09-22
Active, closed
Celltrion
Phase 1
218
Busan, Seongnam-si, Cheongju-si, Seoul
2025-09-17
Recruiting
Seoul National University Hospital
Phase 4
59
Seongnam-si
2025-09-10
Recruiting
BeOne Medicines
Phase 3
500
Seogu, Seongnam-si, Jinju, SeochoGu, SeodaemunGu, Seoul
2025-09-04
Recruiting
CHA University
Observational
100
Seongnam-si
2025-09-01
Recruiting
CHA University
Observational
200
Seongnam-si
2025-09-01
Recruiting
Seoul National University Bundang Hospital
Phase 2
130
Busan, Daegu, Gangneung, Seongnam-si, Incheon, Hwasun, Cheongju-si, Seoul
2025-08-27
Recruiting
BeOne Medicines
Phase 3
351
Seongnam-si, BukGu, GangnamGu, SeodaemunGu, Seoul, SongpaGu
2025-08-27
Recruiting
Relay Therapeutics, Inc.
Phase 3
540
Seongnam-si, Seoul
2025-08-26
Recruiting
University of Minnesota
Observational
1,500
Seongnam-si, Seoul
2025-08-25
Recruiting
Jaseng Medical Foundation
Not applicable
92
Bucheon-si, Seongnam-si, Seoul
2025-08-22
Recruiting
Glaceum
Phase 2
60
Seongnam-si
2025-08-19
Recruiting
Takeda
Phase 3
150
Seongnam-si, Daegu, Seoul
2025-08-14
Recruiting
AstraZeneca
Phase 2
278
Cheongju-si, Namdong-gu, Seongnam-si, Seoul, Suwon
2025-08-07
Recruiting
Bundang CHA Hospital
Not applicable
18
Seongnam-si
2025-08-06
Recruiting
AstraZeneca
Phase 3
700
Busan, Daegu, Goyang-si, Seongnam-si, Seoul
2025-08-06
Active, closed
Seoul National University Bundang Hospital
Not applicable
88
Seongnam-si
2025-08-01
Recruiting
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
NCT06858319Kidney Diseases, Kidney Diseases, Chronic, Urological Diseases, Glomerulonephritis
Novartis Pharmaceuticals
Phase 3
220
Cheonan, Guri-si, Seongnam-si, Seoul
2025-07-28
Recruiting
Celcuity Inc
Phase 3
1,180
Goyang, Incheon, Seongnam-si, Seoul, Suwon, Ulsan
2025-07-24
Recruiting
4D Molecular Therapeutics
Phase 3
480
Seogu, Seoul, Seongnam-si, Daegu
2025-07-22
Active, closed
P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk
NCT06468033Primary Myelofibrosis, Myeloproliferative Neoplasm
PharmaEssentia
Phase 3
160
Daegu, Seongnam-si, Hwasun, Seocho, Seoul
2025-07-18
Recruiting
Daiichi Sankyo
Phase 1
76
Seongnam-si, Seoul
2025-07-17
Recruiting
Merck Sharp & Dohme LLC
Phase 3
477
Goyang-si, Seongnam-si, Suwon, Gangnam, Songpa-gu, Buk-Gu, Seoul
2025-07-16
Recruiting
Takeda
Phase 3
347
Yongin-si, Suwon, Seongnam-si, Seoul
2025-07-15
Active, closed
Long-Term Study of CartiPRO for Knee Pain Due to Osteoarthritis or Cartilage Damage
NCT07267793Osteoarthritis, Knee Pain Arthritis, Cartilage Defects of the Knee, Knee Osteoarthritis
DALIM TISSEN Co., Ltd.
Not applicable
194
Seongnam-si, Seoul
2025-07-03
Active, closed
Upstream Bio Inc.
Phase 2
666
Wŏnju, Seongnam-si, Incheon, Seoul
2025-07-02
Recruiting
Hoffmann-La Roche
Phase 3
80,000
Gwangju, Gyeonggi-do, Incheon, Namdong-gu, Seongnam-si, Seoul, Suwon
2025-07-02
Recruiting
A Study of AMC6156 in People With Sarcopenia
NCT07072195Sarcopenia in Elderly, Sarcopenia
Animuscure Inc.
Phase 2
80
Seongnam-si, Suwon, Seoul
2025-07-01
Recruiting
AstraZeneca
Phase 2
987
Anyang-si, Cheongju-si, Chuncheon, Daegu, Jeonju, Seongnam-si, Seoul, Wŏnju
2025-06-27
Active, closed
Study for Pregnant Women With Insomnia Using Sleep Inducing Digital Sound Application
NCT07266415Insomnia, Pregnancy, First Trimester, Pregnancy, Second Trimester
Seoul National University Bundang Hospital
Not applicable
30
Seongnam-si
2025-06-24
Recruiting
Clinical Outcomes of Primary Cementless Total Hip Arthroplasty Using the Collarless Actis Stem
NCT07828080Osteoarthritis, Hip, Femur Head Necrosis, Femoral Neck Fractures, Arthritis Rheumatoid
Seoul National University Bundang Hospital
Not applicable
210
Seongnam-si
2025-06-18
Active, closed
AbbVie
Phase 3
573
Busan, Daegu, Daejeon, Seongnam-si, Suwon, Gwangju, Seoul
2025-06-17
Recruiting
Seoul National University Bundang Hospital
Observational
150
Seongnam-si
2025-06-13
Recruiting
Streamlining Radioembolization for Small HCC
NCT06979219Hepatocellular Carcinoma (HCC)
Seoul National University Hospital
Observational
146
Goyang, Seongnam-si, Seoul
2025-06-10
Recruiting
BioNTech SE
Phase 3
480
Changwon, Daegu, Goyang, Seongnam, Seongnam-si, Seoul
2025-06-10
Recruiting
STCube, Inc.
Phase 1/2
52
Seongnam-si, Seoul
2025-06-09
Recruiting
SWEEP: Shuttle Walking Test for Exercise Evaluation in Pulmonary Resection
NCT07102589COPD, ILD, Bronchiectasis, Lung Cancer NOS
Seoul National University Bundang Hospital
Observational
100
Seongnam-si
2025-06-01
Recruiting
Regeneron Pharmaceuticals
Phase 2
397
Gyeonggi-do, Seongnam-si, Incheon, Daegu, Seoul
2025-05-28
Recruiting
A First-in-Human Study Using BDC-4182 as a Single Agent in Advanced Gastric and Gastroesophageal Cancer
NCT06921837Gastric Cancer Adenocarcinoma Metastatic, Gastroesophageal Adenocarcinoma
Bolt Biotherapeutics, Inc.
Phase 1/2
122
Seongnam-si, Seoul
2025-05-26
Recruiting
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
NCT06901531Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
Astellas Pharma Global Development, Inc.
Phase 3
500
Goyang-si, Seongnam-si, Suwon, Hwasungun, Cheongju-si, Seocho-gu, Daegu, Incheon
2025-05-22
Recruiting
Medipixel XA-Assisted PCI in Coronary Artery Disease
NCT06985693Percutaneous Coronary Intervention (PCI), Coronary Arterial Disease (CAD)
CHA University
Not applicable
830
Gwangmyeong, Seongnam-si, Daegu, Gwangju, Jeonju, Ulsan
2025-05-15
Active, closed
Seoul National University Bundang Hospital
Phase 1
12
Seongnam-si
2025-05-14
Recruiting
Biogen
Phase 3
454
Busan, Anyang-si, Seongnam-si, Suwon, Seoul
2025-05-08
Recruiting
AstraZeneca
Phase 3
1,220
Busan, Goyang-si, Gyeonggi-do, Seongnam-si, Seoul
2025-05-06
Recruiting
A Study of Lorigerlimab in Participants With Advanced Solid Tumors
NCT06730347Platinum-resistant Ovarian Cancer, Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Primary Peritoneal Carcinoma, Clear Cell Adenocarcinoma of Ovary
MacroGenics
Phase 2
80
Goyang-si, Seongnam-si, Seoul
2025-05-01
Recruiting
Arrowhead Pharmaceuticals
Phase 3
288
Seongnam-si, Jeonju, Busan, Sejong, Seoul
2025-04-24
Recruiting
Seoul National University Bundang Hospital
Observational
500
Seongnam-si
2025-04-21
Recruiting
Post Marketing Study on Pluvicto in Korea
NCT06514521Metastatic Castration-resistant Prostate Cancer
Novartis Pharmaceuticals
Observational
278
Seongnam-si, Suwon, Busan, Gyeonggi-do, Seoul, Jeollanam
2025-04-18
Recruiting
Respiratory Virus Infections in Acute Heart Failure
NCT06967441Acute Heart Failure Syndrome
Minjae Yoon
Observational
360
Seongnam-si, Seoul
2025-04-07
Recruiting
Daiichi Sankyo
Phase 3
510
Daegu, Goyang-si, Hwasun-gun, Incheon, Seongnam-si, Seoul
2025-03-27
Active, closed
Astria Therapeutics, Inc.
Phase 3
157
Seoul, Yangcheon, Seongnam-si
2025-03-20
Active, closed
Hoffmann-La Roche
Phase 4
274
Busan, Daegu, Seongnam-si, Seoul
2025-03-14
Recruiting
AstraZeneca
Phase 3
11,300
Bucheon-si, Cheongju-si, Daegu, Seongnam-si, Seoul, Suwon, Wŏnju, Yangsan
2025-03-14
Recruiting
Long-term Follow up Local Registry Study of Kymriah in South Korea
NCT06785818B-Cell Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma
Novartis Pharmaceuticals
Observational
500
Bundang Gu, Seongnam-si, Gyeonggi-do, Incheon, Seoul, Busan, Jeollanam, Ulsan
2025-03-12
Recruiting
Seoul National University Hospital
Phase 2
100
Gangneung, Anyang-si, Ilsan, Seongnam-si, Seoul
2025-03-11
Recruiting
AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors
NCT06911333Solid Tumor, Adult, Tumor, Solid, Solid Tumor, Solid Tumor, Unspecified, Adult
Avelos Therapeutics Inc.
Phase 1/2
36
Seongnam-si, Seoul
2025-03-11
Recruiting
Hoffmann-La Roche
Phase 2
130
Seongnam-si, Seoul
2025-03-05
Recruiting
AstraZeneca
Phase 3
5,000
Ansan-si, Anyang-si, Busan, Cheonan-si, Goyang-si, Gwangju, Seongnam-si, Seoul
2025-03-03
Recruiting
Takeda
Phase 3
171
Seongnam-si, Daegu, Seoul
2025-02-27
Recruiting
Daiichi Sankyo
Phase 3
726
Cheongju-si, Daegu, Goyang-si, Hwasun-gun, Incheon, Jeonju, Seongnam, Seongnam-si
2025-02-27
Active, closed
Seoul National University Bundang Hospital
Not applicable
100
Seongnam-si
2025-02-26
Recruiting
Intra-lesional Tumor Boost for Bulky Cervical Cancer
NCT07435376Cervical Cancer, Squamous Cell Carcinoma of Cervix
Seoul National University Bundang Hospital
Phase 2
17
Seongnam-si
2025-02-23
Active, closed
Sanofi
Phase 3
231
Cheonan-Si, Seongnam-si, Incheon, Seoul
2025-02-12
Active, closed
A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
NCT06770933Diabetic Retinopathy, NPDR - Non Proliferative Diabetic Retinopathy
Vantage Biosciences Ltd
Phase 2
100
Seongnam-si, Seoul
2025-02-11
Recruiting
Seoul National University Hospital
Phase 4
140
Seongnam-si, Seoul
2025-02-06
Recruiting
Venetoclax and Decitabine in R/R T-ALL
NCT06712121T Lymphoblastic Leukemia/Lymphoma
Seoul National University Hospital
Phase 2
28
Seongnam-si, Seoul
2025-01-30
Recruiting
Korea University Anam Hospital
Observational
80
Seongnam-si, Seoul
2025-01-20
Recruiting
BeOne Medicines
Phase 1
695
PaldalGu SuwonSi, Seongnam-si, GangnamGu, SeodaemunGu, Seoul, SongpaGu
2025-01-10
Active, closed
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
NCT06846541Plaque Psoriasis, Psoriasis (PsO), Psoriasis, Moderate Psoriasis
Alumis Inc
Phase 3
1,680
Seogu, Gwangju, Anyang-si, Seongnam-si, Seoul
2025-01-08
Not yet open
Seoul National University Bundang Hospital
Observational
90
Seongnam-si
2025-01-07
Recruiting
BioNTech SE
Phase 2/3
1,580
Cheongju-si, Daejeon, Goyang-si, Incheon, Jinju, Seongnam-si, Seoul, Suwon
2025-01-07
Active, closed
Pfizer
Phase 3
1,035
Seongnam-si, Incheon, Goyang-si, Seongnam, Gangnam-gu, Seoul
2025-01-06
Recruiting
Seoul National University Bundang Hospital
Phase 4
120
Seongnam-si
2025-01-01
Recruiting
Cilostazol-Ginkgo for Cognitive Function in Elderly Diabetes
NCT06989697Type 2 Diabets Mellitus, Cognitive Ability, General
Seoul National University Bundang Hospital
Phase 3
80
Seongnam-si
2025-01-01
Not yet open
Peripheral Venous Pressure Variation, Pulse Pressure Variation and Pleth Variability Index for Fluid Responsiveness
NCT06733389Pulse Pressure Variation, Stroke Volume Variation, Pleth Variability Index
Seoul National University Bundang Hospital
Observational
150
Seongnam-si
2024-12-28
Not yet open
Deep Learning Model for Predicting a Peripheral Venous Waveform-based Pulse Pressure Variation
NCT06734650Peripheral Vein, Arterial Wave Reflections, Pulse Pressure Variation, Stroke Volume Variation
Seoul National University Bundang Hospital
Observational
150
Seongnam-si
2024-12-28
Active, closed
Sanofi Pasteur, a Sanofi Company
Phase 3
1,714
Busan, Daegu, Gwangju, Ansan-si, Anyang-si, Bucheon-si, Hwaseong-si, Seongnam-si
2024-12-18
Recruiting
Hanmi Pharmaceutical Company Limited
Phase 1
292
Seongnam-si, Seoul
2024-12-11
Recruiting
BeOne Medicines
Phase 1
168
BundangGu SeongnamSi, Seongnam-si, BukGu, NamdongGu, GangnamGu, SeodaemunGu, Seoul, SongpaGu
2024-12-09
Active, closed
Janssen Research & Development, LLC
Phase 3
655
Gwangju, Seongnam-si, Seoul, Suwon
2024-12-04
Active, closed
Daiichi Sankyo
Phase 3
700
Busan, Daegu, Hwasun-gun, Incheon, Jeonju, Seongnam-si, Seoul, Suwon
2024-11-19
Recruiting
Eli Lilly and Company
Phase 3
125
Seongnam-si, Seoul
2024-11-18
Active, closed
A Study of ZW191 in Participants With Solid Tumors
NCT06555744Advanced Solid Tumors
Zymeworks BC Inc.
Phase 1
145
Goyang-si, Seongnam-si, Seoul
2024-10-30
Recruiting
BioMarin Pharmaceutical
Phase 2
100
Seongnam-si, Incheon, Sejong
2024-10-21
Recruiting
BeOne Medicines
Phase 1
153
PaldalGu SuwonSi, Seongnam-si, GangnamGu, SeochoGu, SeodaemunGu, Seoul, SongpaGu
2024-10-18
Active, closed
Ipsen
Observational
424
Busan, Seongnam-si, Seoul
2024-10-14
Recruiting
Rznomics, Inc.
Phase 1/2
43
Incheon, Seongnam-si, Seoul
2024-10-08
Recruiting
Bristol-Myers Squibb
Phase 3
1,000
Cheongju-si, Namdong-gu, Hwasun, Goyang-si, Seongnam-si, Yangsan, Busan, Seoul
2024-10-07
Recruiting
BeOne Medicines
Phase 1
310
Seongnam-si, GangnamGu, SeodaemunGu, SongpaGu
2024-10-03
Recruiting
Yuhan Corporation
Phase 1/2
201
Seongnam-si, Suwon, Cheongju-si, Seoul
2024-10-02
Recruiting
Combination Therapy of GCNT and Tislelizumab in Advanced Biliary Tract Cancer
NCT06893380Locally Advanced Biliary Tract Cancers, Metastatic Biliary Tract Cancers
CHA University
Observational
61
Seongnam-si
2024-10-01
Active, closed
Stemline Therapeutics, Inc.
Phase 3
4,556
Cheongju-si, Seongnam-si, Incheon, Seoul, Busan, Daegu, Gyeonggi-do, Ulsan
2024-09-27
Active, closed
Hoffmann-La Roche
Phase 3
338
Gyeonggi-do, Incheon, Jeollanam-do, Seongnam-si, Seoul
2024-09-23
Recruiting
CHA University
Observational
100
Seongnam-si
2024-09-23
Active, closed
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Phase 3
605
Anyang, Cheonan, Daegu, Daejeon, Gangwon-do, Goyang-si, Seongnam-si, Seoul
2024-08-30
Active, closed
Ferring Pharmaceuticals
Observational
1,526
Busan, Daegu, Seongnam-si, Seoul
2024-08-27
Recruiting
AstraZeneca
Phase 3
620
Busan, Gyeonggi-do, Hwasun-gun, Seongnam-si, Seoul
2024-08-12
Recruiting
CHA University
Phase 4
490
Seongnam-si, Daegu, Iksan, Ilsan, Seongnam, Seoul, Wŏnju
2024-08-05
Recruiting
PulseSelect™ PFA Global Registry
NCT06393920Atrial Fibrillation
Medtronic Cardiac Ablation Solutions
Observational
1,950
Seongnam-si, Seoul
2024-07-23
Recruiting
A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
NCT06427941Metastatic Hepatocellular Carcinoma, Local Advanced Hepatocellular Carcinoma, Alpha-fetoprotein (AFP)-Producing Gastric Cancer, Extragonadal Yolk Sac Tumors
BeOne Medicines
Phase 1/2
630
Cheongju-si, BundangGu SeongnamSi, Seongnam-si, GangnamGu, SeodaemunGu, Seoul, SongpaGu
2024-07-23
Recruiting
Jazz Pharmaceuticals
Phase 3
286
Bundang-Gu, Seongnam-Si, Ilsandong-gu, Goyang-si, Seongnam-si, Busan, Seoul
2024-07-19
Active, closed
Celldex Therapeutics
Phase 3
963
Seongdong, Ansan, Seongnam-si, Seoul, Suwon
2024-07-11
Recruiting
Study of WAL0921 in Patients With Glomerular Kidney Diseases
NCT06466135Diabetic Nephropathies, Primary Focal Segmental Glomerulosclerosis, Minimal Change Disease, Primary Immunoglobulin A Nephropathy
Walden Biosciences
Phase 2
96
Anyang, Busan, Seongnam-si, Seoul, Soeul, Suwon
2024-07-02
Recruiting
Boehringer Ingelheim
Phase 1/2
910
Seongnam-si, Seoul
2024-06-28
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Bucheon-si, Goyang-si, Seongnam-si, Suwon, Yangsan, Busan, Cheongju-si, Daegu
2024-06-25
Active, closed
RCVR (Residual CardioVascular Risk) Prospective Study
NCT06619353Coronary Artery Disease
CHA University
Observational
500
Seongnam-si
2024-06-17
Recruiting
Seoul National University Bundang Hospital
Not applicable
107
Seongnam-si
2024-06-12
Recruiting
Cohort Study for Gastric MALT Lymphoma
NCT06454149Gastric MALT Lymphoma
Seoul National University Hospital
Observational
300
Ansan-si, Seongnam-si, Seoul
2024-06-06
Active, closed
ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer
NCT06328738HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER2 Positive Solid Tumors, HER2 Amplification
Enliven Therapeutics
Phase 1
275
Seongnam-si, Seoul, Soeul, Suwon
2024-05-30
Recruiting
Daiichi Sankyo
Phase 3
540
Cheongju-si, Daegu, Seongnam-si, Seoul, Suwon
2024-05-21
Active, closed
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
NCT06157892Breast Neoplasms, Gastroesophageal Junction Adenocarcinoma, HER2 Low Breast Neoplasms, HER2 Positive Breast Neoplasms
Seagen, a wholly owned subsidiary of Pfizer
Phase 2
54
Seongnam-si, Busan, Goyang-si, Seoul, Cheongju-si, Incheon, Suwon
2024-05-20
Active, closed
Sanofi
Phase 3
1,541
Daegu, Gwangju, Ansan-si, Seongnam-si, Suwon, Yangsan, Bupyeong-gu, Seoul
2024-05-08
Recruiting
Eli Lilly and Company
Phase 3
510
Busan, Gyeonggi-do, Pusan, Seongnam-si, Seoul, Suwon
2024-04-29
Active, closed
Eli Lilly and Company
Phase 3
450
Busan, Incheon, Seongnam-si, Seoul
2024-04-26
Active, closed
AstraZeneca
Phase 2
76
Cheongju-si, Seongnam-si, Seoul, Suwon
2024-04-21
Recruiting
Clopidogrel Versus Cilostazol on Vessels
NCT06402747Type 2 Diabetes, Atherosclerosis
Seoul National University Bundang Hospital
Phase 4
120
Seongnam-si
2024-04-16
Recruiting
A Phase 2b/3 Study of TPX-115 on Partial-thickness Rotator Cuff Tear
NCT06414005Partial Thickness Rotator Cuff Tear
Tego Science, Inc.
Phase 2/3
166
Seongnam-si, Seoul
2024-04-15
Active, closed
L&C Bio
Not applicable
80
Seongnam-si, Seoul
2024-04-01
Recruiting
A Study of VRN110755 in Patients With EGFR-Mutant Non-Small Cell Lung Cancer
NCT07699328EGFR-Mutant Non-Small Cell Lung Cancer
Voronoi, Inc
Phase 1/2
315
Seongnam-si, Suwon, Cheongju-si, Seoul
2024-03-26
Recruiting
Daiichi Sankyo
Phase 2/3
860
Goyang-si, Seongnam, Seongnam-si, Seoul
2024-02-27
Recruiting
A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants
NCT06246123Arthritis, Rheumatoid, Colitis, Ulcerative
Eisai Korea Inc.
Observational
2,040
Cheonan, Chuncheon, Wŏnju, Ansan, Bucheon-si, Goyang-si, Gwangmyeong, Seongnam-si
2024-02-27
Active, closed
NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)
NCT05996003Duchenne Muscular Dystrophy, Exon 44, DMD
NS Pharma, Inc.
Phase 2
20
Seongnam-si, Yangsan, Seoul
2024-02-22
Recruiting
A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers
NCT05910827Advanced or Metastatic Squamous Non-Small Cell Lung Cancer, Advanced Head and Neck Squamous Cell Carcinoma, Advanced Esophageal Squamous Cell Carcinoma, Cervical Squamous Cell Carcinoma
Hummingbird Bioscience
Phase 1/2
398
Cheongju-si, Seongnam-si, Seoul, Suwon
2024-02-05
Recruiting
Seoul National University Bundang Hospital
Phase 4
120
Seongnam-si
2024-02-01
Recruiting
Vividion Therapeutics, Inc.
Phase 1
280
Daegu, Gyeonggi-do, Seongnam-si, Seoul
2024-01-25
Active, closed
Yonsei University
Phase 2
198
Seoul, Goyang-si, Seongnam-si
2024-01-22
Active, closed
Seoul National University Hospital
Phase 2/3
147
Seongnam-si, Seoul
2024-01-19
Active, closed
DualityBio Inc.
Phase 3
541
Busan, Wŏnju, Seongnam-si, Seoul, Suwon, Incheon, Cheonan, Ulsan
2024-01-18
Recruiting
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
NCT06162221Non-Small Cell Lung Cancer, NSCLC, KRAS, NRAS, HRAS-mutated NSCLC, KRAS G12C-mutated Solid Tumors, Lung Cancer, Lung Cancer Stage IV, Advanced Solid Tumor, Cancer
Revolution Medicines, Inc.
Phase 1/2
616
Seoul, Goyang-si, Seongnam-si
2024-01-18
Active, closed
Janssen Research & Development, LLC
Phase 3
774
Busan, Seongnam-si, Seoul
2024-01-17
Active, closed
Kyowa Kirin Co., Ltd.
Phase 2
185
Daegu, Busan, Seongam, Seongnam-si, Incheon, Seoul
2024-01-09
Recruiting
Chong Kun Dang Pharmaceutical
Observational
10,000
Seongnam-si
2024-01-02
Recruiting
Hanmi Pharmaceutical Company Limited
Phase 1
216
Seongnam-si, Seoul
2023-12-28
Active, closed
Sanofi
Phase 3
943
Goyang-si, Seongnam-si, Seoul
2023-12-27
Active, closed
TransThera Sciences (Nanjing), Inc.
Phase 3
200
Seongnam-si, Jinju, Hwasun, Busan, Daegu, Incheon, Seoul
2023-12-20
Active, closed
REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)
NCT05973773Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation
Taiho Oncology, Inc.
Phase 3
285
Seongnam-si, Suwon, Jinju, Incheon, Seoul
2023-12-18
Active, closed
Sanofi
Phase 3
1,655
Goyang-si, Seongnam-si, Seoul
2023-12-13
Recruiting
Eikon Therapeutics
Phase 1/2
156
Seongnam-si, Incheon, Seoul
2023-12-11
Active, closed
AstraZeneca
Phase 3
760
Seongnam-si, Seoul
2023-12-04
Recruiting
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
NCT06120283Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer, Hormone-receptor-positive Breast Cancer
BeOne Medicines
Phase 1
433
Seongnam-si, NamdongGu, GangnamGu, SeochoGu, SeodaemunGu, SeongbukGu, Seoul, SongpaGu
2023-12-01
Recruiting
Akero Therapeutics, Inc
Phase 3
1,650
Daegu, Goyang-si, Incheon, Seongnam-si, Seoul
2023-12-01
Recruiting
Seoul National University Hospital
Not applicable
92
Seongnam-si
2023-11-24
Active, closed
AstraZeneca
Phase 3
1,898
Daejeon, Seongnam-si, Seoul, Suwon
2023-11-21
Recruiting
Seoul National University Hospital
Phase 2
30
Ilsan, Seongnam-si, Seoul
2023-11-20
Recruiting
Comparison of Clopidogrel-based Antiplatelet Agent Treatment and Aspirin Plus Low Dose Rivaroxaban Therapy
NCT07796217Cardiac Event, Coronary Artery Disease, Peripheral Artery Disease, Bleeding
Seoul National University Bundang Hospital
Phase 4
2,758
Seongnam-si
2023-11-15
Active, closed
BeOne Medicines
Phase 3
652
IlsandongGu GoyangSi, Seongnam-si, SeochoGu, SeodaemunGu, Seoul, SongpaGu
2023-11-11
Recruiting
United Therapeutics
Phase 3
698
Incheon, Seongnam-si, Seoul
2023-10-30
Active, closed
Genentech, Inc.
Phase 2
260
Goyang-si, Gyeonggi-do, Seocho, Seongnam-si, Seoul, Songpa-gu
2023-10-18
Recruiting
REBOA in Nontraumatic OHCA
NCT06031623Cardiopulmonary Arrest
Seoul National University Hospital
Not applicable
234
Seongnam-si
2023-10-17
Active, closed
Janssen Research & Development, LLC
Phase 3
311
Busan, Seongnam-si, Seoul
2023-10-12
Recruiting
AbbVie
Phase 3
1,500
Busan, Daegu, Daejeon, Seongnam-si, Incheon, Jeonju, Seoul
2023-10-11
Active, closed
AstraZeneca
Phase 3
5,511
Cheonan-si, Daegu, Goyang-si, Seongnam-si, Seoul
2023-10-05
Recruiting
A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer
NCT06038578Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
Toray Industries, Inc
Phase 2
146
Seongnam-si, Hwasun, Daegu, Seoul
2023-10-04
Recruiting
Pierre Fabre Medicament
Phase 1/2
345
Cheongju-si, Goyang-si, Seongnam-si, Seoul
2023-09-26
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
412
Goyang-si, Seongnam-si, Suwon, Hwasun-gun, Iksan-si, Busan, Incheon, Seoul
2023-09-22
Active, closed
Bridge Biotherapeutics, Inc.
Phase 1/2
24
Seongnam-si, Seoul
2023-09-11
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
500
Buk-gu, Seongnam-si, Incheon, Seoul, Busan
2023-08-28
Recruiting
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
NCT05875168Advanced Solid Tumor, Metastatic Solid Tumor
Daiichi Sankyo
Phase 1/2
590
Goyang, Seongnam-si, Seoul
2023-08-18
Active, closed
Regeneron Pharmaceuticals
Phase 2/3
160
Seongnam-si, Suwon, Incheon, Cheongju-si, Daejeon, Seoul, Ulsan
2023-08-08
Active, closed
Hoffmann-La Roche
Phase 3
459
Anyang-si, Bucheon-si, Cheongju-si, Gyeonggi-do, Seongnam-si, Seoul
2023-08-08
Recruiting
A Study of TXN10128 in Subjects With Solid Tumors
NCT05978492Locally Advanced (Unresectable) or Metastatic Solid Tumors
Txinno Bioscience Inc.
Phase 1
96
Seongnam-si, Cheonju, Seoul, Incheon
2023-07-27
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
1,000
Buk-gu, Ansan-si, Seongnam-si, Yongin-si, Incheon, Seoul, Yeongdeungpo-gu, Gangwon-do
2023-07-11
Active, closed
AstraZeneca
Phase 3
111
Gyeonggi-do, Seongnam-si, Seoul
2023-06-27
Recruiting
Seoul National University Bundang Hospital
Phase 4
56
Seongnam-si
2023-06-01
Recruiting
Hoffmann-La Roche
Phase 3
200
Goyang-si, Gyeonggi-do, Seongnam-si, Seoul
2023-06-01
Active, closed
Janssen Research & Development, LLC
Phase 2
68
Cheongju-si, Gyeonggi-do, Incheon, Jeollanam-do, Seongnam-si, Seoul
2023-05-18
Active, closed
AstraZeneca
Phase 3
37
Cheongju-si, Donggu, Goyang-si, Seongnam-si, Seoul
2023-05-08
Active, closed
AstraZeneca
Phase 2
294
Seongnam-si, Seoul
2023-04-24
Active, closed
Karyopharm Therapeutics Inc
Phase 3
257
Seongnam-si, Seoul
2023-04-18
Active, closed
Seoul National University Bundang Hospital
Not applicable
40
Seongnam-si
2023-04-07
Recruiting
Seoul National University Bundang Hospital
Observational
1,240
Daegu, Gyeonggi-do, Hwasun, Ilsan, Jinju, Seongnam-si, Seoul, Yangsan
2023-04-01
Recruiting
Iovance Biotherapeutics, Inc.
Phase 3
670
Seongnam-si, Seoul
2023-03-30
Recruiting
Bundang CHA Hospital
Observational
2,000
Seongnam-si
2023-03-23
Active, closed
AbbVie
Phase 3
520
Goyang-si, Seongnam, Seongnam-si, Daegu, Seoul
2023-03-15
Active, closed
Seoul National University Hospital
Not applicable
44
Seongnam-si
2023-03-09
Active, closed
AstraZeneca
Phase 2
188
Busan, Cheongju-si, Daejeon, Goyang-si, Gyeonggi-do, Incheon, Seongnam-si, Seoul
2023-03-06
Recruiting
Eli Lilly and Company
Phase 3
595
Busan, Cheonan-si, Daejeon, Incheon, Jeonju, Junggu, Seongnam-si, Seoul
2023-02-27
Active, closed
Regeneron Pharmaceuticals
Phase 2
120
Seongnam-si, Busan, Daegu, Seoul
2023-02-09
Active, closed
Stemline Therapeutics, Inc.
Phase 1/2
435
Seongnam-si, Seoul
2023-01-24
Active, closed
ABTECT - Maintenance
NCT05535946Ulcerative Colitis
Abivax S.A.
Phase 3
1,116
Wŏnju, Seongnam-si, Suwon, Daegu, Ansan-si, Busan, Daejeon, Incheon
2023-01-16
Active, closed
Qurient Co., Ltd.
Phase 1/2
120
Seongnam-si, Seoul
2023-01-12
Active, closed
Daiichi Sankyo
Phase 3
1,233
Cheongju-si, Daegu, Gangnam-Gu, Goyang-si, Jinju-si Gyeongsangnam-do, Seongnam-si, Seoul
2023-01-11
Active, closed
Exelixis
Phase 3
317
Busan, Daegu, Daejeon, Goyang-si, Gyeonggi-do, Seongnam-si, Seoul
2023-01-01
Recruiting
Anthos Therapeutics, Inc.
Phase 3
2,500
Anyang-si, Busan, Daegu, Daejeon, Goyang-si, Gwangju, Gyeonggi-do, Seongnam-si
2022-12-27
Active, closed
AriBio Co., Ltd.
Phase 3
1,535
Seongnam-si, Gwangju, Seoul, Chuncheon, Incheon, Cheonan, Daegu, Guri-si
2022-12-23
Active, closed
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
NCT05476926Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, Branch Retinal Vein Occlusion
Hoffmann-La Roche
Observational
6,000
Seongnam-si, Daegu
2022-11-21
Recruiting
Janssen Research & Development, LLC
Phase 2
520
Goyang-si, Seongnam-si, Seoul
2022-11-11
Active, closed
Hoffmann-La Roche
Phase 3
68
Daegu, Gyeongsangnam-do, Jeollanam-do, Seongnam-si, Seoul
2022-11-01
Active, closed
Novo Nordisk A/S
Phase 3
3,400
Bucheon-si, Seongnam-si, Yangsan, Daegu, Daejeon, Incheon, Seongnam-si, Gyeonggi-do, Seoul
2022-11-01
Recruiting
Dual-chamber Patient-controlled Analgesia for Postoperative Recovery
NCT07051109Morbid Obesity, PCA, Analgesia, PONV
Seoul National University Bundang Hospital
Not applicable
92
Seongnam-si
2022-10-11
Active, closed
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
NCT05508789Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases
Eli Lilly and Company
Phase 3
1,500
Busan, Guri-si, Gwangju, Incheon, Junggu, Namdong-gu, Seongnam, Seongnam-si
2022-10-10
By invitation
Comparison Study Between Suction Aspiration and Combination Technique in Acute Cerebral Infarction
NCT06254755Acute Cerebral Ischemia Requiring for Mechanical Thrombectomy
Inje University Haeundae Paik Hospital
Not applicable
1,132
Goyang-si, Seongnam-si, Changwon, Bucheon-si, Daegu, Daejeon, Incheon, Pohang
2022-10-01
Recruiting
Seoul National University Bundang Hospital
Phase 4
105
Seongnam-si
2022-10-01
Active, closed
Exelixis
Phase 3
901
Goyang-si, Gyeonggi-do, Hwasun, Seongnam-si, Seoul
2022-09-07
By invitation
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
NCT04905693Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Progressive Pulmonary Fibrosis
United Therapeutics
Phase 3
1,850
Seongnam-si, Incheon, Seoul
2022-09-06
Recruiting
Qurient Co., Ltd.
Phase 1/2
130
Daegu, Goyang-si, Seongnam-si, Seoul, Suwon
2022-08-30
Recruiting
Yuhan Corporation
Phase 1/2
147
Seongnam-si, Suwon, Jinju, Cheongju-si, Incheon, Seoul, Ulsan
2022-08-26
Active, closed
Sanofi
Phase 2/3
1,856
Daegu, Gwangju, Ansan-si, Seongnam-si, Suwon, Yangsan, Bupyeong-Gu, Seoul
2022-08-22
Active, closed
EMD Serono Research & Development Institute, Inc.
Phase 2
256
Daejeon, Gyeonggi-do, Seongnam-si, Seoul
2022-08-17
Active, closed
Janssen Research & Development, LLC
Phase 3
418
Gyeonggi-do, Gyeongsangnam-do, Jeollanam-do, Seongnam-si, Seoul
2022-08-05
Active, closed
Genentech, Inc.
Phase 3
373
Cheongju-si, Dongnam-gu, Cheonan-si, Goyang-si, Seongnam-si, Seoul
2022-08-03
Recruiting
CHA University
Not applicable
240
Cheonan, Ansan-si, Goyang-si, Seongnam-si, Yangsan, Changwon, Hwasun, Busan
2022-08-01
Recruiting
SupporTive Care At Home Research for Patients With Advanced Cancer (STAHR-cancer)
NCT05636384Malignant Neoplasm, Home Care Services, Quality of LIfe, Unplanned Hospitalization
Seoul National University Hospital
Not applicable
396
Goyang-si, Seongnam-si, Seoul
2022-07-25
Active, closed
Janssen Research & Development, LLC
Phase 2
703
Busan, Daegu, Goyang-si, Gwangju, Hwaseong-si, Seongnam-si, Seoul, Suwon
2022-07-22
Active, closed
Gilead Sciences
Phase 3
623
Goyang-si Gyeonggi-do, Seongnam-si, Seoul
2022-07-20
Recruiting
Astellas Pharma Inc
Phase 1
681
Goyang-si, Seongnam-si, Cheongju-si, Jongno -Gu, Seodaemun-gu, Songpa-gu, Seoul
2022-06-08
Recruiting
Astellas Pharma Global Development, Inc.
Phase 1
398
Seongnam-si, Guro-gu, Jongno-gu, Seocho-gu, Seodaemun-gu
2022-06-07
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2
83
Busan, Cheongju-si, Gyeonggi-do, Seongnam, Seongnam-si, Seoul
2022-05-30
Recruiting
AstraZeneca
Phase 2
630
Busan, Chungcheongbuk-do, Seongnam-si, Seoul, Suwon
2022-04-14
Recruiting
Seoul National University Bundang Hospital
Phase 2
28
Seongnam-si
2022-04-01
Recruiting
GOG Foundation
Not applicable
840
Seongnam-si, Seoul
2022-03-22
Active, closed
BeOne Medicines
Phase 3
799
BusanjinGu, Seogu, Seongnam-si, BukGu, Jinju, HwasunGun, GangnamGu, SeochoGu
2022-03-10
Recruiting
ORIC Pharmaceuticals
Phase 1/2
350
Cheongju-si, Goyang-si, Gyeonggi-do, Incheon, Seongnam-si, Seoul
2022-03-10
Active, closed
Daiichi Sankyo
Phase 2
187
Goyang-si, Seongnam-si, Seoul
2022-03-09
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
654
Wŏnju, Goyang-si, Seongnam-si, Suwon, Cheongju-si, Seoul, Busan, Incheon
2022-03-07
Active, closed
Daiichi Sankyo
Phase 3
740
Seongnam-si, Jinju, Cheongju-si, Daegu, Goyang-si, Seoul, Songpa-gu
2022-03-04
Recruiting
Seoul National University Bundang Hospital
Not applicable
338
Seongnam-si
2022-02-27
Active, closed
AstraZeneca
Phase 3
1,051
Changwon-si, Cheongju-si, Seongnam-si, Seoul, Suwon
2022-02-07
Active, closed
Ascendis Pharma Oncology Division A/S
Phase 1/2
320
Seoul, Seongnam-si
2022-01-11
Recruiting
Seoul National University Bundang Hospital
Phase 3
130
Seongnam-si
2022-01-03
Active, closed
AstraZeneca
Phase 2
126
Seongnam-si, Seoul
2021-12-10
Active, closed
Jazz Pharmaceuticals
Phase 3
920
Anyang-si, Busan, Daegu, Goyang-si, Incheon, Seongnam-si, Seoul
2021-12-02
Active, closed
Hoffmann-La Roche
Phase 3
660
Cheongju-si, Daegu, Gyeongsangnam-do, Seongnam-si, Seoul, Ulsan
2021-11-18
Active, closed
Seoul National University Bundang Hospital
Not applicable
108
Seongnam-si
2021-11-15
Active, closed
Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants
NCT04988386Amyloid Cardiomyopathy, Transthyretin-Related
Eidos Therapeutics, a BridgeBio company
Phase 3
389
Seongnam-si, Seoul
2021-10-27
Active, closed
ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)
NCT04829604HER2 Positive Metastatic Breast Cancer
DrugARX788
Ambrx, Inc.
Phase 2
72
Daegu, Seongnam-si, Seoul
2021-10-26
Recruiting
Bayer
Phase 1/2
430
Seongnam-si, Suwon, Chungcheongbuk-do, Jongno -Gu, Seoul
2021-10-25
Recruiting
Hoffmann-La Roche
Phase 1
542
Goyang-si, Jeollanam-do, Seongnam-si, Seoul
2021-10-22
Recruiting
Pfizer
Phase 3
893
Seongnam-si, Hwasun-gun, Busan, Seoul, Daegu, Incheon
2021-10-04
Active, closed
A Beta-only IL-2 ImmunoTherapY Study
NCT05086692Advanced Solid Tumor, Unresectable Solid Tumor, Clear Cell Renal Cell Carcinoma, Triple Negative Breast Cancer
Medicenna Therapeutics, Inc.
Phase 1/2
160
Seoul, Seongnam-si
2021-08-27
Active, closed
HUYABIO International, LLC.
Phase 3
450
Goyang-si, Seongnam-si, Seoul, Hwasun, Daejeon
2021-08-12
Active, closed
Hoffmann-La Roche
Phase 3
451
Busan, Daegu, Incheon, Seongnam-si, Seoul
2021-07-14
Active, closed
AstraZeneca
Phase 3
315
Cheonan-si, Daegu, Goyang-si, Seongnam-si, Seoul
2021-06-30
Active, closed
Mirati Therapeutics Inc.
Phase 3
461
Anyang-si, Busan, Daejeon, Goyang-si, Hwasun-gun, Seongnam-si, Seoul, Suwon
2021-06-24
Active, closed
ALX Oncology Inc.
Phase 2
172
Cheongju-si, Daegu, Incheon, Seongnam, Seongnam-si, Seoul
2021-05-10
Recruiting
Ipsen
Phase 1/2
240
Goyang-si, Incheon, Seongnam-si, Seoul
2021-04-29
Recruiting
Bundang CHA Hospital
Observational
200
Seongnam-si
2021-04-21
Active, closed
IDEAYA Biosciences
Phase 1
169
Goyang-si, Seongnam-si, Cheongju-si, Seoul
2021-04-14
Recruiting
Guerbet
Phase 4
2,076
Chuncheon, Gwangju, Seongnam-si, Busan, Seoul
2021-03-24
Active, closed
Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer
NCT04938583Ovarian Cancer by FIGO Stage, Ovarian Cancer Stage III, Ovarian Cancer Stage IV
CanariaBio Inc.
Phase 1/2
54
Seoul, Daegu, Seongnam-si
2021-03-17
Active, closed
Karyopharm Therapeutics Inc
Phase 3
353
Busan, Seongnam-si, Hwasun, Daegu, Seoul
2021-03-11
Active, closed
Celgene
Phase 3
313
Daegu, Hwasun-Gun, Seongnam-si, Seoul
2021-02-25
Active, closed
Mirati Therapeutics Inc.
Phase 3
453
Busan, Cheongju-si, Daegu, Hwasun-gun, Incheon, Junggu, Seongnam-si, Seoul
2021-02-23
Active, closed
Anthos Therapeutics, Inc.
Phase 2
1,287
Seogu, Seongnam-si, Seoul
2021-02-02
Recruiting
Tegoprazan-containing Sequential for H. Pylori
NCT06382493Helicobacter Pylori Infection
Seoul National University Bundang Hospital
Not applicable
400
Seongnam-si
2021-02-01
Active, closed
Seoul National University Bundang Hospital
Not applicable
141
Seongnam-si
2021-02-01
Active, closed
Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
NCT04579380Uterine Neoplasms, Uterine Cervical Neoplasms, Biliary Tract Neoplasms, Urologic Neoplasms
Seagen, a wholly owned subsidiary of Pfizer
Phase 2
217
Seongnam-si, Seoul
2021-01-11
Active, closed
Daiichi Sankyo
Phase 3
605
Cheongju-si, Daegu, Gyeonggi-do, Seongnam-si, Seoul
2020-12-21
Active, closed
Atrasentan in Patients With IgA Nephropathy
NCT04573478IgA Nephropathy, Immunoglobulin A Nephropathy
Novartis Pharmaceuticals
Phase 3
404
Anyang, Daejeon, Gyeonggi-do, Jeju City, Seongnam-si, Seoul
2020-12-11
Active, closed
AstraZeneca
Phase 3
957
Hwasun-gun, Seongnam-si, Seoul
2020-11-17
Recruiting
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
NCT04606446Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer
Pfizer
Phase 2
320
Seongnam-si, Seoul, Daegu
2020-11-16
Active, closed
Janssen Research & Development, LLC
Phase 1
158
Cheongju-si, Seongnam-si, Seoul
2020-11-10
Active, closed
Exelixis
Phase 3
575
Junggu, Goyang-si, Seongnam-si, Hwasun, Busan, Daegu, Gwangju, Seoul
2020-10-19
Active, closed
Janssen Research & Development, LLC
Phase 3
308
Busan, Gyeonggi-do, Gyeongsangnam-do, Jeollanam-do, Seongnam-si, Seoul
2020-10-13
Active, closed
AstraZeneca
Phase 3
370
Busan, Cheongju-si, Goyang-si, Seongnam-si, Seoul
2020-10-02
Active, closed
Janssen Research & Development, LLC
Phase 3
1,074
Busan, Cheongju-si, Seongnam-si, Seoul
2020-09-30
Active, closed
Genentech, Inc.
Phase 1
498
Seongnam-si, Seoul
2020-07-29
Active, closed
AstraZeneca
Phase 3
866
Daegu, Goyang-si, Incheon, Seongnam-si, Seoul
2020-07-24
Active, closed
AstraZeneca
Phase 3
1,012
Daegu, Goyang-si, Seongnam-si, Seoul
2020-07-13
Active, closed
Merck Sharp & Dohme LLC
Phase 3
870
Goyang-si, Seongnam-si, Suwon, Jinju, Cheongju-si, Daegu, Seoul
2020-07-06
Recruiting
Seoul National University Bundang Hospital
Not applicable
100
Seongnam-si
2020-07-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
520
Gyeonggi-do, Seongnam-si, Daejeon, Seoul
2020-05-19
Active, closed
AstraZeneca
Phase 3
818
Busan, Daegu, Goyang-si, Incheon, Seongnam-si, Seoul, Suwon
2020-04-16
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
886
Daejeon, Goyang-si, Hwasun, Seongnam-si, Seoul
2020-03-30
Active, closed
Efficacy and Safety of GENOSS® SES in Patients With Acute Coronary Syndrome (GENOSS ACS)
NCT06075368Acute Coronary Syndrome, Percutaneous Coronary Intervention
Genoss Co., Ltd.
Observational
757
Seongnam-si
2020-03-16
Active, closed
Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)
NCT04152499Epithelial Ovarian Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Urothelial Carcinoma
Klus Pharma Inc.
Phase 1/2
1,410
Seongnam-si, Busan, Daegu, Goyang-si, Gyeonggi-do, Incheon, Seoul
2020-02-28
Active, closed
Eli Lilly and Company
Phase 3
261
Goyang-si, Seongnam-si, Incheon, Seoul, Jinju, Dongjak-gu, Daejeon
2020-02-17
Active, closed
Advanced Accelerator Applications
Phase 3
226
Seongnam-si, Seoul
2020-01-08
Active, closed
Regeneron Pharmaceuticals
Phase 1/2
95
Gyeonggi-do, Seongnam-si, Suwon, Pusan, Hwasun, Incheon, Cheongju-si, Busan
2020-01-07
Active, closed
Pfizer
Phase 3
1,068
Goyang-si, Seongnam-si, Seoul, Daegu
2019-12-30
Recruiting
Inhibrx Biosciences, Inc
Phase 1/2
340
Busan, Cheongju-si, Gyeonggi-do, Hwasun, Incheon, Seongnam-si, Seoul, Suwon
2019-12-10
Active, closed
Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors
NCT04140500Solid Tumors, Metastatic Melanoma, Non-small Cell Lung Cancer, Esophageal Squamous Cell Carcinoma
Hoffmann-La Roche
Phase 1/2
170
Seongnam-si, Seoul
2019-11-11
Active, closed
Seoul National University Hospital
Not applicable
620
Seongnam-si
2019-10-30
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
466
Goyang-si, Seongnam-si, Seoul
2019-10-02
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,064
Busan, Daegu, Gyeonggi-do, Incheon, Seongnam-si, Seoul, Suwon
2019-09-26
Active, closed
Janssen Research & Development, LLC
Phase 1
701
Seongnam-si, Seoul
2019-09-04
Recruiting
Bristol-Myers Squibb
Phase 2
1,500
Seongnam-si, Seoul, Gyeonggi-do, Suwon
2019-08-09
Active, closed
AstraZeneca
Phase 2
247
Seongnam-si, Seoul
2019-06-25
Active, closed
AstraZeneca
Phase 3
923
Busan, Cheonan-si, Cheongju-si, Daegu, Goyang-si, Incheon, Seongnam-si, Seoul
2019-06-25
Active, closed
AstraZeneca
Phase 3
810
Seongnam-si, Seoul
2019-04-16
Active, closed
Eisai Inc.
Phase 3
1,906
Seongnam-si, Gwangju, Busan, Incheon, Seoul
2019-03-27
Active, closed
A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer
NCT03816163Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc.
Phase 2
393
Seongnam-si, Suwon, Daegu, Gyeonggi-do, Seoul
2019-03-15
Active, closed
Janssen Research & Development, LLC
Phase 3
765
Busan, Daegu, Daejeon, Gwangju, Gyeonggi-do, Seongnam-si, Seoul
2019-01-25
Active, closed
AstraZeneca
Phase 2
367
Goyang-si, Seongnam-si, Seoul, Suwon
2019-01-09
Recruiting
Clinicopathological Characteristics of Colon Cancer in Young Age
NCT05365412Colo-rectal Cancer, Molecular Pathway Deregulation
Seoul National University Bundang Hospital
Observational
1,400
Seongnam-si
2019-01-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
714
Hwasun Gun, Goyang-si, Seongnam-si, Suwon, Seoul
2018-12-17
Active, closed
AstraZeneca
Phase 3
825
Busan, Cheongju-si, Seongnam-si, Seoul, Suwon
2018-12-06
Active, closed
OBI Pharma, Inc
Phase 3
575
Busan, Goyang-si, Incheon, Seongnam-si, Seoul, Suwon
2018-12-05
Active, closed
A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).
NCT03653507Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
Astellas Pharma Global Development, Inc.
Phase 3
507
Daegu, Goyang-si, Gyeonggi-do, Incheon, Jeollanam-do, Jeonju, Seongnam-si, Seoul
2018-11-28
Active, closed
AstraZeneca
Phase 3
730
Changwon-si, Cheongju-si, Daegu, Goyang-si, Jinju, Seongnam-si, Seoul, Suwon
2018-09-27
Recruiting
Novartis Pharmaceuticals
Observational
700
Daegu, Seongnam-si, Seoul, Yangsan, Yongin-si
2018-09-25
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,500
Inceon, Hwasun, Goyang-si, Seongnam-si, Suwon, Cheongju-si, Gangnam-gu, Songpagu
2018-08-21
Active, closed
AstraZeneca
Phase 3
216
Cheongju-si, Incheon, Seongnam-si, Seoul
2018-07-19
Recruiting
Xynomic Pharmaceuticals, Inc.
Phase 3
413
Goyang-si, Seongnam-si, Seoul
2018-07-17
Active, closed
A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer
NCT03505320Pharmacokinetics of Zolbetuximab, Gastric Cancer, Gastro-esophageal Junction (GEJ) Cancer, Pharmacokinetics of Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 2
143
Seongnam-si, Seoul
2018-06-29
Active, closed
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
NCT03625037DLBCL, High-grade B-cell Lymphoma (HGBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL), FL
Genmab
Phase 1/2
666
Busan, Daegu, Goyang-si, Jeonju, Seongnam-si, Seoul
2018-06-26
Active, closed
A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.
NCT03504397Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
Astellas Pharma Global Development, Inc.
Phase 3
565
Seongnam-si, Suwon, Seoul, Incheon
2018-06-21
Active, closed
pharmaand GmbH
Phase 3
1,097
Goyang-si, Seongnam-si, Incheon, Cheonan, Seoul, Suwon
2018-05-14
Active, closed
Bristol-Myers Squibb
Phase 3
545
Suwon, Seoul, Daegu, Goyang-si, Gyeongsangnam-do, Jeollanam-do, Seongnam-si
2018-04-18
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,409
Ansan-si, Busan, Daegu, Gyeonggi-do, Hwaseong-si, Seongnam, Seongnam-si, Seoul
2018-04-13
Active, closed
AbbVie
Phase 3
1,336
Busan, Daegu, Daejeon, Guri-si, Seongnam-si, Suwon, Seoul
2018-04-09
Active, closed
AbbVie
Phase 3
747
Busan, Daegu, Guri-si, Seongnam-si, Dongjak-gu, Seoul
2018-03-21
Active, closed
AstraZeneca
Phase 2
273
Cheongju-si, Daegu, Goyang-si, Incheon, Seongnam-si, Seoul
2018-03-07
Active, closed
Daehwa Pharmaceutical Co., Ltd.
Phase 2/3
549
Wŏnju, Goyang-si, Seongnam-si, Suwon, Cheongju-si, Busan, Daegu, Daejeon
2017-12-18
Active, closed
AstraZeneca
Phase 3
1,324
Ilsan, Seongnam-si, Busan, Daegu, Seoul
2017-10-11
Active, closed
AstraZeneca
Phase 3
1,186
Busan, Chungcheongbuk-do, Daegu, Incheon, Seongnam-si, Seoul, Ulsan
2017-06-01
Active, closed
AstraZeneca
Phase 3
987
Changwon, Cheongju-si, Daegu, Incheon, Jinju, Seongnam-si, Seoul
2017-03-27
Recruiting
Ju Seok Ryu
Not applicable
200
Seongnam-si
2016-12-29
Active, closed
Astellas Pharma Global Development, Inc.
Phase 2
900
Busan, Seongnam-si, Seoul
2016-12-22
Active, closed
Janssen Biotech, Inc.
Observational
535
Busan, Gyeonggi-do, Seongnam-si, Seoul
2016-12-16
Recruiting
Prospective Cohort Study of Rapid Response Team
NCT02986581Hospital Medical Emergency Team, Medicine, Emergency, Hospital Rapid Response Team
Seoul National University Hospital
Observational
79,800
Seongnam-si
2016-11
Active, closed
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
NCT02864992Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV
EMD Serono Research & Development Institute, Inc.
Phase 2
337
Busan, Daegu, Goyang-si, Hwasun-gun, Incheon, Seongnam-si, Seoul, Suwon
2016-09-13
Active, closed
Janssen Research & Development, LLC
Phase 1
751
Cheongju-si, Goyang-si, Incheon, Seongnam-si, Seoul
2016-05-24
Active, closed
AstraZeneca
Phase 1/2
264
Goyang-si, Seongnam-si, Seoul
2016-03-17
Active, closed
Tesaro, Inc.
Phase 1
729
Changwon, Gwangju, Seongnam-si, Seongnam-si Gyeonggi-do, Seoul
2016-03-07
Recruiting
Korean Idiopathic Pulmonary Fibrosis Registry
NCT04160715Idiopathic Pulmonary Fibrosis
Seoul National University Hospital
Observational
3,000
Seongnam-si
2016-01
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,052
Daegu, Daejeon, Goyang-si, Jeollanam-do, Seongnam-si, Seoul
2015-11-27
Active, closed
AstraZeneca
Phase 3
1,126
Incheon, Seongnam-si, Seoul
2015-11-02
Active, closed
MedImmune LLC
Phase 2
433
Busan, Junggu, Seongnam-si, Seoul
2015-10-19
Active, closed
Seoul National University Bundang Hospital
Observational
582
Seongnam-si
2015-03-01
Active, closed
Pfizer
Phase 3
1,068
Seongnam-si, Yangsan, Hwasun-gun, Incheon, Seoul
2014-12-17
Active, closed
Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents
NCT02264678Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer
AstraZeneca
Phase 1
358
Goyang-si, Seongnam-si, Seoul
2014-10-31
Active, closed
AstraZeneca
Phase 1
344
Cheongju-si, Goyang-si, Seongnam-si, Seoul
2014-08-05
Recruiting
Seoul National University Hospital
Observational
3,000
Seongnam-si, Seoul
2014-08
Recruiting
Seoul National University Bundang Hospital
Not applicable
600
Seongnam-si
2014-08
Active, closed
AstraZeneca
Phase 3
1,837
Daegu, Goyang-si, Incheon, Seongnam-si, Seoul
2014-04-22
Recruiting
Predictors of Prognosis in IBD Patients
NCT05653011Inflammatory Bowel Diseases, Ulcerative Colitis, Crohn Disease
Seoul National University Bundang Hospital
Observational
100
Seongnam-si
2013-03-11
Recruiting
Seoul National University Airway Registry
NCT02527486Chronic Obstructive Pulmonary Disease (COPD), Asthma, Asthma With Chronic Obstructive Pulmonary Disease, Bronchiectasis
Seoul National University Hospital
Observational
800
Seongnam-si, Seoul
2011-09
Active, closed
Janssen Scientific Affairs, LLC
Observational
21,190
Busan, Gyeonggi-do, Seongnam-si, Seoul, Sungnam
2007-06-21
Recruiting
Prevalence and Trends of Antimicrobial Resistance of Helicobacter Pylori in Korea
NCT05247112Helicobacter Pylori Infection, Helicobacter Pylori Associated Gastrointestinal Disease, Helicobacter Pylori Infection, Susceptibility to, Helicobacter Pylori 23S rRNA Clarithromycin Resistance Mutation
Seoul National University Bundang Hospital
Observational
2,000
Seongnam-si
2003-07-01
Active, closed
Seoul National University Bundang Hospital
Observational
24,000
Seongnam-si
2003-03-01
Recruiting
Medtronic
Observational
20,000
Busan, Cheongju-si, Daegu, Daejeon, Gwangju, Gyeonggi-do, Jeonju, Seongnam-si
1983-01
Rows per page Showing 1–482 of 482
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a South Korean investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 16 November 2026. https://priyalifescience.com/clinical-trials-south-korea/city/seongnam-si

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in South Korea and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,401 studies in total at the last sync on 13 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 482 of those studies with a site in Seongnam-si.

How many clinical trials are recruiting in Seongnam-si?

246 of the 482 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:18 UTC sync. A further 20 have not yet opened recruitment, 211 are active but closed to new participants, and 5 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Seongnam-si), 482 studies
PhaseStudiesRecruitingShare
Phase 32098643.4%
Phase 2743615.4%
Observational543711.2%
Not applicable44219.1%
Phase 1/237257.7%
Phase 133196.8%
Phase 417143.5%
Phase 2/31482.9%

Most active sponsors

Lead sponsors with the most studies (Seongnam-si)
Lead sponsorStudiesRecruiting
AstraZeneca5923
Seoul National University Bundang Hospital5129
Hoffmann-La Roche2511
Seoul National University Hospital2116
Janssen Research & Development, LLC172
Daiichi Sankyo138
Merck Sharp & Dohme LLC136
AbbVie125
BeOne Medicines1210
CHA University128
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.